ArticleBJC reports2025

A retrospective study of the impact of comorbidity, polypharmacy and demographic factors on patient inclusion and healthcare delivery in phase I oncology trials.

Hoda Nemat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.